Randomized trial · people
NMN did not improve grip strength or walking speed in 24 weeks
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In this small human trial, NMN looked safe over 24 weeks but did not make older men with diabetes stronger or faster on their feet.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 14
- Published
- 2023
- Journal
- Geriatr Gerontol Int
What they tested
The team tested whether taking NMN by mouth is safe and whether it improves grip strength and walking speed in older men with diabetes who had weak physical performance.
How the study was done
A randomized, double-blind, placebo-controlled trial in 14 men with diabetes, aged 65 or older (average age 81.1), who had low grip strength (under 26 kg) or slow walking speed (under 1.0 m/s). Over 24 weeks, the NMN arm took 250 mg/day and was compared with a placebo, a dummy pill.

What they found
NMN was well tolerated, and no one had a severe side effect. Grip strength changed by 1.25 kg in the NMN group and by -0.44 kg in the placebo group. Walking speed changed by 0.033 m/s with NMN and by 0.014 m/s with placebo. Neither change differed between the groups, and none of the other measures differed either. Frailty became less common in the NMN group, and central retinal thickness changed differently between groups, but neither result reached statistical significance (P = 0.066 and P = 0.051).
What it doesn’t show
This was a very small trial of 14 men, all older and with diabetes, so it can't show whether NMN helps women, younger people or people without diabetes. At 24 weeks and one dose, it also can't show longer-term or dose-related effects.
The paper
Akasaka et al. Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study. Geriatr Gerontol Int. 2023.
The compound
More studies on NMN
- NMN: no significant benefit on blood sugar or lipids in pooled trialsMeta-analysis · people · 2024
- NMN raised serum nicotinamide over 12 weeks in middle-aged adultsRandomized trial · people · 2023
- NMN (MIB-626) raised blood NAD levels in older adults over 14 daysRandomized trial · people · 2023
- NMN: raised blood NAD over 60 days in 80 middle-aged adultsRandomized trial · people · 2023
- NMN supplements raised blood NAD+ levels in healthy older menRandomized trial · people · 2022
- NMN raised muscle insulin sensitivity in women with prediabetesRandomized trial · people · 2021
- Every study on NMN
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.